ArticleBMJ open2024

Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial.

Daniel Thomas-Rüddel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.